Events
Conferences we attend
Upcoming Conferences
Virtual or in person, we participate in many conferences as speakers, exhibitors or attendees.
We regularly attend conferences organised by the American Chemical Society (ACS), the Royal Society of Chemistry, The International Society for the Study of Xenobiotics (ISSX), the Drug Metabolism Discussion Group (DMDG) the Society of Chemical Industry (SCI), the Pharmaceutical and Bioscience Society (PBSS) and The Boston Society.
Let us know if you’d like to connect at any of the meetings we’re attending this year.
Our partner BioBridge will be representing Hypha at the 37th annual meeting of The Japanese Society for the Study of Xenobiotics (JSSX)
Frank Scheffler will be attending KSNS The multiverse of new therapeutics via emerging biotechnologies in South Korea from 5-6 October 2022.
Samuel Coe will be exhibiting at the DMDG 2022 joint meeting being held 3-5 October 2022 in Amsterdam.
Samuel Coe will be attending the Oxford BioForward Event on 27th September 2022. Let us know if you’d like to meet with Sam.
Sam will be presenting a poster at the RSC Chemical Biology meets Drug Discovery meeting being held 12-13 September 2022 on “PolyCYPs: Biocatalytic Tools for the Optimisation of Drug Leads”
Hypha are sponsoring the Applied Pharmaceutical Analysis 2022 meeting being held 19-21 September in Boston. Frank will be happy to meet with you at our booth.
Hypha will be exhibiting at ISSX/MDO 2022 from 11-14 September in Seattle. Julia and Frank will be there – please drop by booth 28 and say hello.
Hypha will be exhibiting at the EFMC-ISMC 2022 conference being held in Nice, France on 4-8 September. Come and meet Frank and Sam at booth 16.
Hypha will be exhibiting at the ACS Fall 2022 event being held 21-25 August in Chicago. Our CEO Liam Evans will be attending. Please drop by booth 232 if you are also attending.
Stay up to date with the latest news from Hypha Discovery
Sign up for our Newsletter to receive interesting updates and scientific case studies about Hypha’s metabolite generation capabilities and lead optimization solutions
Ready to begin? Our scientists are available to talk through your requirements
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.